In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People Briefs: New CEO At DFINE; CMS Departure; FDA Seeks CIO

This article was originally published in The Gray Sheet

Executive Summary

DFINE taps new president and CEO. CMS Program Integrity chief Peter Budetti steps down. FDA searching for new chief information officer. More personnel announcements from Endo Health Solution, STAAR Surgical and Solulink.

You may also be interested in...



News Briefs: CMS Sunshine Rule User Guide; Bard Acquisition; Sapien Japan Reimbursement

CMS releases user guide and manual for companies to comply with the Physician Payments Sunshine Act rule provisions. CR Bard acquires Medafor to add to its Davol surgical specialties unit. More news.

People In Brief

BD appoints new CFO. DJO Global names new president of global recovery sciences. CytoSorbents taps new European director of scientific affairs.

The Renal Denervation Buzz: Separating Fact From Myth

Is renal denervation the next blockbuster device technology? Judging by the excitement at the EuroPCR meeting in May, the potential is there. Just before the meeting, Covidien announced its acquisition of renal denervation start-up Maya Medical.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel